UNDIFFERENTIATED SARCOMA

Clinical trials for UNDIFFERENTIATED SARCOMA explained in plain language.

Never miss a new study

Get alerted when new UNDIFFERENTIATED SARCOMA trials appear

Sign up with your email to follow new studies for UNDIFFERENTIATED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1

New chemo cocktail shows promise against aggressive childhood cancer

Disease control Ongoing

This study tested a combination of two chemotherapy drugs, irinotecan and carboplatin, as the first treatment for children and adults newly diagnosed with intermediate- or high-risk rhabdomyosarcoma, a type of muscle cancer. The goal was to see if this drug pair could shrink tumo…

Matched conditions: UNDIFFERENTIATED SARCOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

UNDIFFERENTIATED SARCOMA

Get alerted when new UNDIFFERENTIATED SARCOMA trials appear

New chemo cocktail shows promise against aggressive childhood cancer